This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
First data on the disease associated with vaping in Colombia / Primeros datos de la enfermedad asociada al vapeo en Colombia / Primeiros dados sobre a doença associada à vaporização na Colômbia
Preprint
in English
| SciELO Preprints
| ID: pps-7197
Responsible library:
BR1.1
ABSTRACT
Background Electronic cigarettes are a mass consumption product with great market penetration, particularly among groups of young adults. Recently, attention has been drawn to the increasingly frequent reports of cases with vaping-related disease, leading to hospitalizations and death. Methods An ecological study was designed to characterize the use of these devices and the demand for vaping-related consultations in Colombia between 2020 and 2022. The National Health Service Registries and the 2019 National Survey of Psychoactive Consumption were used as data sources. Results Young adults and residents of Bogotá, Caldas, Antioquia, Valle del Cauca, and Boyacá had the highest consumption of e-cigarettes. Their consumption was associated with cigarette and marijuana use. The greatest reports of vaping-related disease occurred in adults over 45 years of age residing in the departments of Antioquia and Boyacá. 245 cases of vaping-related disease were reported. A total of 59 deaths were reported in the period evaluated. The data suggest that in Colombia users are older than in other countries, which seems to relate to the costs associated with the devices. Preventive actions should begin at an early age, although adverse effects may not be observed until years later. In addition, there is a need to fill the knowledge gaps among health care professionals' and the clinical skills to identifying and reporting vaping-related disease. Decision makers can already have data that allow health policies that prevent use and decrease cases of vaping-related disease.
Full text:
Available
Collection:
Preprints
Health context:
Sustainable Health Agenda for the Americas
Health problem:
Goal 3 Human resources for health
Database:
SciELO Preprints
Country/Region as subject:
South America
/
Colombia
Language:
English
Year:
2023
Document type:
Preprint